Absorbance correction method for simultaneous estimation of Amlodipine besylate and Simvastatin in synthetic mixture

  • Vandana Patel Shree Dhanvantary College of Pharmacy,
  • Hasumati Raj Shree Dhanvantary College of Pharmacy,
  • Vineet Jain Shree Dhanvantary College of Pharmacy,
Keywords: Amlodipine besylate, Simvastatin, Absorption correction Method

Abstract

A simple, accurate and precise spectroscopic method was developed for simultaneous estimation of Amlodipine besylate and Simvastatin in synthetic mixture using Absorbance correction  method. At  360.80  nm (λmax of Amlodipine besylate) Simvastatin has zero absorbance so Amlodipine besylate is directly estimate at 360.80 nm. At 237.60 nm (λmax of Simvastatin) both drugs have some absorbance so Simvastatin is estimate at 237.60 nm using absorbance correction method. The method was found to be linear (r2>0.999) in the range of 5-10 μg/ml for Amlodipine besylate at 360.80 nm. The linear correlation was obtained (r2>0.999) in the range of 5-10 μg/ml for Simvastatin at 237.60 nm. The limit of determination was 0.17 μg/ml and 0.10μg/ml for Amlodipine besylate and Simvastatin, respectively. The limit of quantification was 0. 54μg/ml and 0. 32μg/ml for Amlodipine besylate  and Simvastatin, respectively. The accuracy of these method were evaluated by recovery studies and good recovery result were obtained greater than 99%. The method was successfully applied for simultaneous determination of Amlodipine besylate and Simvastatin in binary mixture.

Author Biographies

Vandana Patel, Shree Dhanvantary College of Pharmacy,

Shree Dhanvantary College of Pharmacy,
Kim, Surat, Gujarat, India.

Hasumati Raj, Shree Dhanvantary College of Pharmacy,

Shree Dhanvantary College of Pharmacy,
Kim, Surat, Gujarat, India.

Vineet Jain, Shree Dhanvantary College of Pharmacy,

Shree Dhanvantary College of Pharmacy,
Kim, Surat, Gujarat, India.

References

1. Hypertension-KD Tripathi. Medical Pharmacology; 6th Edn; Jaypee Brothers Medical Publishers (p) Ltd,New Delhi, 2008, pp 539.
2. Drug profile available from: en.wikepedia.org/wiki/Amlodipine besylate
3. Drug Profile available from: chemicalland21.com/Amlodipine besylate
4. Mechanism action available from: drugsbank.com/Amlodipine besylate
5. Drug profile available from: drugsbank.com/Simvastatin
6. Introduction available on : medicine net.com
7. Moshe FB, Itzhak EL, Naomi M, Vered R and Teva pharma. Simvastatin formulations and methods of making same. WIPO WO2005044258 A1, 2004.
8. Sung W, Sung S, Youg G, Ja-seongkod and Jin W.Combined pharmaceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors. WIPO WO 2008023958 A1, 2007.
9. Beckett AH, Stenlake JB, Davidson AG. Ultraviolet-Visible absorption spectrophotometry, Practical Pharmaceutical Chemistry, 4th Edn; New Delhi, CBS Publishers, 2002, pp 275-300.
10. International Conference on Harmonization, Harmonized Tripartite Guideline, Validation of Analytical Procedures Text and Methodology, ICH Q2(R1), 2005.
Published
2015-06-01
How to Cite
[1]
Patel, V., Raj, H. and Jain, V. 2015. Absorbance correction method for simultaneous estimation of Amlodipine besylate and Simvastatin in synthetic mixture. PharmaTutor. 3, 6 (Jun. 2015), 35-40.
Section
Articles